Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Exploring cognitive reserve in multiple sclerosis: New findings from a cross-sectional study.
Emerging Role of P2X7 Receptors in CNS Health and Disease.
Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome.
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
Gender, ethnicity, and physician-patient communication about depression and anxiety in primary care.
The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.
Is It worth Considering Circulating microRNAs in Multiple Sclerosis?
Role of Pulmonary Evaluation in Diagnosis of Neurosarcoidosis.
GENETIC POLYMORPHISMS OF HUMAN β-DEFENSINS IN PATIENTS WITH MULTIPLE SCLEROSIS.
Key players in neurodegenerative disorders in focus - new insights into the proteomic profile of Alzheimer`s disease, schizophrenia, ALS and multiple sclerosis - 24th HUPO BPP Workshop: 29 September 2015, Vancouver, Canada.
Splenic Marginal Zone Lymphoma: An indolent malignancy leading to the development of neurolymphomatosis.
B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.
Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics.
MicroRNA223 Promotes Pathogenic T Cell Development and Autoimmune Inflammation in Central Nerve System in Mice.
Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland In 2013.
The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
CellCept Drug Details
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome.
Pediatric idiopathic transverse myelitis presenting as an anterior cord syndrome: A case report.
A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights.
Disability may influence patient willingness to participate in decision making on first-line therapy in multiple sclerosis.
Inside front cover: Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain.
Pages
« first
‹ previous
…
723
724
725
726
727
728
729
730
731
…
next ›
last »